Cara Mathews

8PUBLICATIONS

101CO-AUTHORS

Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|May 11, 2026

First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL-2 in Patients with High-Grade Serous Ovarian Carcinoma.

|Jan 09, 2025

Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial.

Jyoti Mayadev, Dmitriy Zamarin, Wei Deng

|May 22, 2024

Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study.

Charles N Landen, Ronald J Buckanovich, Michael W Sill

|Jan 09, 2024

Normal Risk Ovarian Screening Study: 21-Year Update.

Chae Young Han, Karen H Lu, Gwen Corrigan

|Aug 31, 2023

Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study.

Ignace Vergote, Els Van Nieuwenhuysen, Roisin E O'Cearbhaill

|Jun 26, 2023

Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study.

Ana Oaknin, Bhavana Pothuri, Lucy Gilbert

Pageof 2

Frequent Collaborators

Susana Banerjee

Roisin O'Cearbhaill

Heather A Lankes

Joyce Liu

Ana Oaknin

Kathleen N Moore

Krishnansu S Tewari

David Mutch

Giovanni Scambia

Paul DiSilvestro

Frequent Collaborators

Susana Banerjee

Roisin O'Cearbhaill

Heather A Lankes

Joyce Liu